Literature DB >> 7563099

A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection?

D M Yellon1, G F Baxter.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7563099     DOI: 10.1016/0022-2828(95)90071-3

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  31 in total

1.  Conditioned medium from hypoxic cells protects cardiomyocytes against ischemia.

Authors:  B Chanyshev; A Shainberg; A Isak; Y Chepurko; E Porat; E Hochhauser
Journal:  Mol Cell Biochem       Date:  2011-12-08       Impact factor: 3.396

Review 2.  Nitrite as a mediator of ischemic preconditioning and cytoprotection.

Authors:  Daniel Murillo; Christelle Kamga; Li Mo; Sruti Shiva
Journal:  Nitric Oxide       Date:  2011-01-26       Impact factor: 4.427

Review 3.  Coronary vasoregulation in health and disease.

Authors:  John G Kingma; Jacques R Rouleau
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

4.  Delayed cardioprotection is associated with the sub-cellular relocalisation of ventricular protein kinase C epsilon, but not p42/44MAPK.

Authors:  S Wilson; W Song; K Karoly; T Ravingerova; A Vegh; J Papp; S Tomisawa; J R Parratt; N J Pyne
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

5.  Plasma nitric oxide metabolite levels increase during successive exercise stress testing - A link to delayed ischemic preconditioning?

Authors:  Dumitru Zdrenghea; György Bódizs; Mihai Claudiu Ober; Maria Ilea
Journal:  Exp Clin Cardiol       Date:  2003

Review 6.  Delayed myocardial protection following ischaemic preconditioning.

Authors:  G F Baxter; D M Yellon
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

7.  Protection from preconditioning can be reinstated at various reperfusion intervals.

Authors:  E K Iliodromitis; C Papadopoulos; I A Paraskevaidis; Z S Kyriakides; C Flessa; D T Kremastinos
Journal:  Cardiovasc Drugs Ther       Date:  1996-07       Impact factor: 3.727

8.  Role of nitric oxide synthases in the infarct size-reducing effect conferred by heat stress in isolated rat hearts.

Authors:  C Arnaud; A Laubriet; M Joyeux; D Godin-Ribuot; L Rochette; P Demenge; C Ribuot
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 9.  Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology.

Authors:  Tána Ravingerová; Miroslav Barancík; Monika Strnisková
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

Review 10.  Preconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practice.

Authors:  D P Jenkins; S E Steare; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.